Related Experiment Video
Updated: Apr 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Duration of chronic kidney disease reduces attention and executive function in pediatric patients
Susan R Mendley1, Matthew B Matheson2, Shlomo Shinnar3
1University of Maryland School of Medicine, Baltimore, Maryland, USA.
Insights
Longer duration of childhood chronic kidney disease (CKD) is linked to poorer attention and inhibitory control. This finding emerged from a study of pediatric patients with mild-to-moderate CKD.
Area of Science:
- Pediatric Nephrology
- Neuropsychology
- Child Health
Background:
- Childhood chronic kidney disease (CKD) is associated with neurocognitive deficits.
- Children with CKD often exhibit lower intelligence test scores compared to healthy siblings.
Purpose of the Study:
- To investigate the association between CKD severity (eGFR, duration) and neurocognitive deficits in pediatric patients.
- To identify specific cognitive functions affected by mild-to-moderate CKD in children.
Main Methods:
- Assessed 340 pediatric patients (ages 6-21) with mild-to-moderate CKD using neurocognitive tests.
- Utilized Conners' Continuous Performance Test-II (CPT-II), Delis-Kaplan Executive Function System Tower, and Digit Span Backward tasks.
- Analyzed performance in relation to estimated glomerular filtration rate (eGFR) and CKD duration, controlling for covariates.
Main Results:
- 35% of patients showed poor performance on at least one executive function test.
- Longer CKD duration, not eGFR, was significantly associated with impaired attention regulation and inhibitory control (CPT-II Errors of Commission).
Conclusions:
- In pediatric mild-to-moderate CKD, disease duration is a key factor impacting attention and inhibitory control.
- Neurocognitive deficits, particularly in executive functions, are prevalent in children with CKD.
Abstract:
Chronic kidney disease (CKD) in childhood is associated with neurocognitive deficits. Affected children show worse performance on tests of intelligence than their unaffected siblings and skew toward the lower end of the normal range. Here we further assessed this association in 340 pediatric patients (ages 6-21) with mild-moderate CKD in the Chronic Kidney Disease in Childhood cohort from 48 pediatric centers in North America. Participants underwent a battery of age-appropriate tests including Conners' Continuous Performance Test-II (CPT-II), Delis-Kaplan Executive Function System Tower task, and the Digit Span Backward task from the age-appropriate Wechsler Intelligence Scale. Test performance was compared across the range of estimated glomerular filtration rate and duration of CKD with relevant covariates including maternal education, household income, IQ, blood pressure, and preterm birth. Among the 340 patients, 35% had poor performance (below the mean by 1.5 or more standard deviations) on at least one test of executive function. By univariate nonparametric comparison and multiple logistic regression, longer duration of CKD was associated with increased odds ratio for poor performance on the CPT-II Errors of Commission, a test of attention regulation and inhibitory control. Thus, in a population with mild-to-moderate CKD, the duration of disease rather than estimated glomerular filtration rate was associated with impaired attention regulation and inhibitory control.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion